Alanosine in Treating Patients With Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2009

Conditions
Lung CancerMalignant MesotheliomaPancreatic CancerSarcoma
Interventions
DRUG

L-alanosine

Trial Locations (12)

10011

St. Vincent's Comprehensive Cancer Center - Manhattan, New York

10021

Memorial Sloan-Kettering Cancer Center, New York

33428

Lynn Regional Cancer Center West, Boca Raton

60077

Midwest Cancer Research Group, Incorporated, Skokie

77030

MD Anderson Cancer Center at University of Texas, Houston

77060

U.S. Oncology, Incorporated, Houston

85724

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

90048

Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles

91750

Wilshire Oncology Medical Group, Incorporated - La Verne, La Verne

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

60637-1470

University of Chicago Cancer Research Center, Chicago

37232-6838

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00062283 - Alanosine in Treating Patients With Cancer | Biotech Hunter | Biotech Hunter